Who Paid My Doc
Jeffrey Dell
Gynecology Knoxville, TN Medical Doctor
NPI 1952355075 CMS profile 618082
10133 Sherrill Blvd Ste 100, Ste 100, Knoxville, TN 37932
General payments
$8,127
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Jeffrey Dell of Knoxville, TN is reported in the CMS Open Payments database as having received $8,127 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 90th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $2,182 | 4 | |
| 2023 | General | $116 | 2 | |
| 2022 | General | $153 | 4 | |
| 2020 | General | $1,401 | 10 | |
| 2019 | General | $4,275 | 3 |
Beside peers
- Jeffrey Dell
- Gynecology median
- Middle half of Gynecology
- National median
In program year 2025, general payments to Jeffrey Dell were reported at $0. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.
Show as a table
| Year | Jeffrey Dell | Gynecology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $4,275 | $199 | $66–$472 | $163 |
| 2020 | $1,401 | $114 | $42–$287 | $114 |
| 2021 | $0 | $141 | $42–$430 | $132 |
| 2022 | $153 | $173 | $52–$532 | $149 |
| 2023 | $116 | $170 | $57–$501 | $160 |
| 2024 | $2,182 | $157 | $50–$424 | $164 |
| 2025 | $0 | $162 | $56–$501 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 34 drugsPart D claims
1,604
Drug cost
$215,609
Branded share of claims
52.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Gemtesa Vibegron | Brand | 112 | $94,023 | |
| Myrbetriq Mirabegron | Brand | 133 | $89,542 | |
| Solifenacin Succinate | Generic | 106 | $4,340 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 223 | $3,849 | |
| Estradiol | Generic | 69 | $3,786 | |
| Heparin Sodium Heparin Sodium,porcine | Brand | 22 | $2,949 | |
| Methenamine Hippurate | Generic | 42 | $2,432 | |
| Clobetasol Propionate | Generic | 42 | $2,073 | |
| Cefdinir | Generic | 52 | $1,989 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 123 | $1,989 |
The 10 drugs with the highest cost, of 34 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 41 billing codesPaid by Medicare
$425,829
Medicare patients
702
Services billed
9,243
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Arthritis | 59% | |
| Depression | 27% | |
| Osteoporosis | 26% | |
| Diabetes | 18% | |
| Chronic kidney disease | 16% | |
| Ischemic heart disease | 15% | |
| Cancer | 13% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, onabotulinumtoxina, 1 unit J0585 | Office | 16 | 3,300 | $16,342 |
| Injection, heparin sodium, per 1000 units J1644 | Office | 13 | 1,320 | $220 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Gynecology in Tennessee
Related records
Gynecology in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Gynecology
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.